Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Bring Christensen

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Danish Medical Journal|April 2, 2016
Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humansMikkel Bring Christensen
Danish Medical Journal|August 4, 2020
Prevalence of polypharmacy in DenmarkJonatan Kornholt, Mikkel Bring Christensen
Basic & Clinical Pharmacology & Toxicology|January 10, 2018
A Systematic Review on Insulin Overdose Cases: Clinical Course, Complications and Treatment OptionsNicklas Järvelä Johansen, Mikkel Bring Christensen
Ugeskrift for Laeger|October 28, 2023
Pernille Hølmkjær, Mikkel Bring Christensen, Gitte Krogh Madsen, et al.
Ugeskrift for Laeger|May 5, 2024
Mariam Nersesjan, Simon Carstensen Nersesjan, Lars Pedersen, et al.
Ugeskrift for Laeger|November 20, 2020
[Multidisciplinary treatment of acute iron poisoning due to suicide attempt]Stine Mette Petersen, Trine Boysen, Maria Saur Svane, et al.
Expert Opinion on Pharmacotherapy|February 29, 2020
Clinical pharmacology of imeglimin for the treatment of type 2 diabetesKarl Sebastian Johansson, Andreas Brønden, Filip Krag Knop, et al.
Scandinavian Journal of Gastroenterology|February 1, 2019
Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?Mia Noergaard, Jon Traerup Andersen, Espen Jimenez-Solem, et al.
Drugs & Aging|September 1, 2023
Methodological Considerations for Describing Medication Changes in Relation to Clinical Events and Death: An Applied Example in Patients with Type 2 Diabetes and CancerKarl Sebastian Johansson, Tonny Studsgaard Petersen, Mikkel Bring Christensen, et al.
Expert Opinion on Drug Discovery|October 20, 2018
Preclinical discovery and development of colesevelam for the treatment of type 2 diabetesHenriette Holst Nerild, Mikkel Bring Christensen, Filip Krag Knop, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Danish Medical Journal|April 2, 2016
Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humansMikkel Bring Christensen
Danish Medical Journal|August 4, 2020
Prevalence of polypharmacy in DenmarkJonatan Kornholt, Mikkel Bring Christensen
Basic & Clinical Pharmacology & Toxicology|January 10, 2018
A Systematic Review on Insulin Overdose Cases: Clinical Course, Complications and Treatment OptionsNicklas Järvelä Johansen, Mikkel Bring Christensen
Ugeskrift for Laeger|October 28, 2023
Pernille Hølmkjær, Mikkel Bring Christensen, Gitte Krogh Madsen, et al.
Ugeskrift for Laeger|May 5, 2024
Mariam Nersesjan, Simon Carstensen Nersesjan, Lars Pedersen, et al.
Ugeskrift for Laeger|November 20, 2020
[Multidisciplinary treatment of acute iron poisoning due to suicide attempt]Stine Mette Petersen, Trine Boysen, Maria Saur Svane, et al.
Expert Opinion on Pharmacotherapy|February 29, 2020
Clinical pharmacology of imeglimin for the treatment of type 2 diabetesKarl Sebastian Johansson, Andreas Brønden, Filip Krag Knop, et al.
Scandinavian Journal of Gastroenterology|February 1, 2019
Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?Mia Noergaard, Jon Traerup Andersen, Espen Jimenez-Solem, et al.
Drugs & Aging|September 1, 2023
Methodological Considerations for Describing Medication Changes in Relation to Clinical Events and Death: An Applied Example in Patients with Type 2 Diabetes and CancerKarl Sebastian Johansson, Tonny Studsgaard Petersen, Mikkel Bring Christensen, et al.
Expert Opinion on Drug Discovery|October 20, 2018
Preclinical discovery and development of colesevelam for the treatment of type 2 diabetesHenriette Holst Nerild, Mikkel Bring Christensen, Filip Krag Knop, et al.
Pageof 5